Study shows how cancer can act as a systemic disease
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century…
Study uncovers hidden switch that helps cancer cells to evade immune detection
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have…
Integrated nanomaterials offer new strategies for cancer immunotherapy
Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not achieve…
Microbiome-based therapy may increase peanut allergy tolerance in adults
Some 33 million Americans have severe food allergies. Now, researchers at Boston Children’s Hospital may have found a…
Discovery may help develop new treatments for immunosuppressed skin cancer patients
Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those…
NIH funds research to explore the role of thymulin in inflammaging and cancer
As we age, chronic inflammation-or “inflammaging”-increases throughout the body and weakens our ability to fight cancer. But scientists…
Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery…
New ultrasound technique breaches blood brain barrier to treat gliomas
In a promising sign for the potential of focused sound waves to improve care for brain tumors, UVA…
New strategy combines cancer immunotherapy and gene therapy in a single nanoparticle
Cancer cells survive by hiding from the immune system’s surveillance. A KAIST research team has developed a new…
Engineered probiotic bacteria boost immune attack against pancreatic cancer
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major…
Mass-producible immune cells fight solid human tumors in mice
Off-the-shelf and mass-producible immune cells fight solid human tumors engrafted into mice. The Kobe University development is a…
Wistar scientists develop new bispecific T cell engager to target ovarian cancer
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…